Edwards Lifesciences (EW)
(Delayed Data from NYSE)
$63.74 USD
+1.37 (2.20%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $63.73 -0.01 (-0.02%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 40% (100 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 2.32 | 1.57 | 9.99 |
Current Quarter Estimate | 0.68 | 3.93 | 61.00 |
Year Ago Quarter Estimate | 0.59 | 3.85 | 54.84 |
Next Quarter Estimate | 0.69 | 3.92 | 63.00 |
Next Year Estimate | 2.89 | 19.76 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 7.97 | 12.00 | 15.67 |
Next Year | 6.64 | 21.90 | 9.31 |
Last 5 Years | 9.90 | 10.20 | 8.10 |
Next 5 Years | 9.90 | 14.10 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 24.08 | 29.13 |
Price/Book (MRQ) | 5.01 | 2.46 |
Price/Cash Flow (MRFY) | 22.57 | 17.35 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 24.55% | 4.75% |
Return on Equity (TTM) | 22.35% | 9.10% |
Debt to Equity (MRQ) | 0.08 | 30.84 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.